Unit Code 81602:
Antimicrobial Susceptibility Panel, Yeast
Useful For 
Suggests clinical disorders or settings where the test may be helpful
Determining in vitro quantitative antifungal susceptibility (minimum
inhibitory concentration; MIC) of nonfastidious yeast.
Testing may be warranted to aid in the management of certain
circumstances, such as:
- Refractory oropharyngeal infections due to Candida species in patients
who appear to be experiencing therapeutic failure with standard agents
at standard doses
- Invasive infections due to Candida species when the utility of azole
antifungal agents is uncertain (eg, when the infection is due to a non-
Candida albicans organism)
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Minimum Inhibitory Concentration (MIC)
Antifungals included in the assay are:
amphotericin B, anidulafungin, caspofungin fluconazole,
5-flucytosine, itraconazole, micafungin, posaconazole,
and voriconazole.
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Susceptibility Panel, Yeast
Ordering Mnemonic An alternate Mayo code (to the Unit Code) for a test
MMLYP
Aliases Lists additional common names for a test, as an aid in searching
Abelcet (Amphotericin B)
Amphotericin B (Abelcet)
Ancobon (5-Flucytosine)
Anidulafungin (ERAXIS)
CANCIDAS (Caspofungin)
Caspofungin (CANCIDAS)
Diflucan (Fluconazole)
ERAXIS (Anidulafungin)
Fluconazole (Diflucan)
Flucytosine (Ancobon)
Itraconazole (Sporanox)
Micafungin (Mycamine)
Mycamine (Micafungin)
NOXAFIL (Posaconazole)
Posaconazole (NOXAFIL)
Soft-MMLYP
Sporanox (Itraconazole)
Susceptibility Panel, Yeast
Susceptibility Testing
Vfend (Voriconazole)
Voriconazole (Vfend)
Yeast Susceptibility Panel
External
link
PDF
document
Excel
document
Word
document